Hindustan Zinc Board Meeting Outcome

Hindustan Zinc Earnings Call Transcript: Key Takeaways

Management reported record profitability driven by lowest-ever zinc production costs despite global volatility.

Hindustan Zinc Investor Presentation: Key Takeaways

Hindustan Zinc reported record Q2FY27 performance with revenue of ₹15,093 crore (up 77% YoY) and EBITDA of ₹9,285 crore. Growth driven by record production, higher metal prices, and significant silver profitability contribution (45%).

Hindustan Zinc Results Update

Hindustan Zinc posted record Q2 FY27 net profit of ₹6,412 crore and EBITDA of ₹9,285 crore. 1H revenue hit a record ₹28,840 crore.

Hindustan Zinc Q2 FY27 Results: Net Profit ₹6,412 Cr, Up 142.1% YoY

Hindustan Zinc Ltd reported revenue from operations of ₹15,093 Cr (+76.5% YoY) and net profit of ₹6,412 Cr (+142.1% YoY) for Q2 FY27.

Key figure

Net profit ₹6,412 Cr · +142.1% YoY

Hindustan Zinc Annual General Meeting

Hindustan Zinc's postal ballot concluded, with shareholders approving the appointment of Mr. Amarendu Prakash as Whole-time Director/CEO and Dr. Yogesh Attray as Independent Director.

Hindustan Zinc Other Announcement

Hindustan Zinc Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.